Acasti Pharma Inc Files For Shelf Of Up To 6.6M Common Shares By Selling Stockholders
Portfolio Pulse from Benzinga Newsdesk
Acasti Pharma Inc has filed for a shelf of up to 6.6 million common shares by selling stockholders, according to an SEC filing.

October 06, 2023 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acasti Pharma's filing for a shelf of up to 6.6 million common shares could potentially dilute the value of existing shares.
The filing for a shelf of up to 6.6 million common shares by Acasti Pharma could lead to dilution of the value of existing shares. This is because the introduction of more shares into the market increases the supply, which could potentially lower the price per share if demand does not increase proportionately.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100